Healthcare provider profile · identity verified

Mark Ww Bogel, MD

Family Practice · NORTH ST PAUL, MN · NPI 1699782359

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	737	207
Lisinopril	Lisinopril	466	121
Losartan Potassium	Losartan Potassium	457	129
Simvastatin	Simvastatin	425	106
Rosuvastatin Calcium	Rosuvastatin Calcium	382	117
Levothyroxine Sodium	Levothyroxine Sodium	366	94
Omeprazole	Omeprazole	343	92
Amlodipine Besylate	Amlodipine Besylate	334	94
Metoprolol Succinate	Metoprolol Succinate	290	86
Tamsulosin Hcl	Tamsulosin Hcl	275	77
Metformin Hcl	Metformin Hcl	264	74
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	262	56
Hydrochlorothiazide	Hydrochlorothiazide	224	64
Gabapentin	Gabapentin	217	70
Furosemide	Furosemide	208	72
Glipizide Er	Glipizide	188	54
Allopurinol	Allopurinol	171	43
Albuterol Sulfate Hfa	Albuterol Sulfate	169	45
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	162	22
Metformin Hcl Er	Metformin Hcl	160	48
Atenolol	Atenolol	159	42
Pantoprazole Sodium	Pantoprazole Sodium	156	41
Oxycodone Hcl	Oxycodone Hcl	155	38
Metoprolol Tartrate	Metoprolol Tartrate	139	38
Potassium Chloride	Potassium Chloride	136	40
Sertraline Hcl	Sertraline Hcl	129	33
Trazodone Hcl	Trazodone Hcl	126	39
Warfarin Sodium	Warfarin Sodium	120	32
Eliquis	Apixaban	119	34
Finasteride	Finasteride	99	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	23
Pravastatin Sodium	Pravastatin Sodium	93	26
Ozempic	Semaglutide	91	18
Pioglitazone Hcl	Pioglitazone Hcl	91	26
Prednisone	Prednisone	91	75
Escitalopram Oxalate	Escitalopram Oxalate	85	25
Lorazepam	Lorazepam	83	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	25
Famotidine	Famotidine	78	24
Irbesartan	Irbesartan	74	18
Alprazolam	Alprazolam	73	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	17
Duloxetine Hcl	Duloxetine Hcl	69	19
Carvedilol	Carvedilol	68	15
Citalopram Hbr	Citalopram Hydrobromide	67	19
Fluoxetine Hcl	Fluoxetine Hcl	67	18
Jardiance	Empagliflozin	65	20
Mirtazapine	Mirtazapine	64	19
Triamcinolone Acetonide	Triamcinolone Acetonide	64	36
Zolpidem Tartrate	Zolpidem Tartrate	64	11
Ezetimibe	Ezetimibe	63	20
Tramadol Hcl	Tramadol Hcl	63	11
Fluticasone Propionate	Fluticasone Propionate	59	21
Pregabalin	Pregabalin	59	15
Azithromycin	Azithromycin	56	50
Quetiapine Fumarate	Quetiapine Fumarate	53	16
Montelukast Sodium	Montelukast Sodium	51	14
Bupropion Xl	Bupropion Hcl	49	13
Ropinirole Hcl	Ropinirole Hcl	49	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	46	suppressed
Trulicity	Dulaglutide	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	17
Methylphenidate Hcl	Methylphenidate Hcl	39	suppressed
Amoxicillin	Amoxicillin	38	32
Alendronate Sodium	Alendronate Sodium	37	11
Ibuprofen	Ibuprofen	37	14
Lovastatin	Lovastatin	37	14
Doxycycline Hyclate	Doxycycline Hyclate	36	32
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	36	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	11
Aripiprazole	Aripiprazole	34	suppressed
Celecoxib	Celecoxib	33	13
Cephalexin	Cephalexin	33	27
Xarelto	Rivaroxaban	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Baclofen	Baclofen	30	13
Glimepiride	Glimepiride	30	suppressed
Methylprednisolone	Methylprednisolone	30	29
Valacyclovir	Valacyclovir Hcl	30	17
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	14
Clotrimazole	Clotrimazole	27	11
Spironolactone	Spironolactone	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Oxycontin	Oxycodone Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Glipizide	Glipizide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Cefdinir	Cefdinir	22	19
Fenofibrate	Fenofibrate	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	17
Ventolin Hfa	Albuterol Sulfate	22	11
Benazepril Hcl	Benazepril Hcl	21	suppressed
Diazepam	Diazepam	21	suppressed
Fluconazole	Fluconazole	21	11
Propranolol Hcl	Propranolol Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Methadone Hcl	Methadone Hcl	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Estradiol	Estradiol	18	suppressed
Fentanyl	Fentanyl	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Lactulose	Lactulose	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Bydureon Bcise	Exenatide Microspheres	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Digoxin	Digoxin	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error